Cargando…
Inhibition of Topoisomerase II by a Novel Antitumor Cyclic Depsipeptide, BE‐22179
BE‐22179, a novel cyclic depsipeptide antibiotic having two 3‐hydroxyquinoline moieties, inhibited the DNA‐relaxing activity of L1210 topoisomerase II completely at 0.08 μM. This effect was far stronger than that of VP‐16. However, it did not show any marked effect on topoisomerase II‐mediated DNA c...
Autores principales: | Yoshinari, Tomoko, Okada, Hiromasa, Yamada, Akihiro, Uemura, Daisuke, Oka, Hirofumi, Suda, Hiroyuki, Okura, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919495/ https://www.ncbi.nlm.nih.gov/pubmed/8014113 http://dx.doi.org/10.1111/j.1349-7006.1994.tb02394.x |
Ejemplares similares
-
Structural Diversity and Biological Activities of Cyclic Depsipeptides from Fungi
por: Wang, Xiaohan, et al.
Publicado: (2018) -
Total Synthesis of the Cyclic Depsipeptide Vioprolide D via its (Z)‐Diastereoisomer
por: Grab, Hanusch A., et al.
Publicado: (2020) -
Stereo(C7)‐dependent Topoisomerase II Inhibition and Tumor Growth Suppression by a New Quinolone, BO‐2367
por: Yoshinari, Tomoko, et al.
Publicado: (1993) -
ED‐110, a Novel Indolocarbazole, Prevents the Growth of Experimental Tumors in Mice
por: Arakawa, Hiroharu, et al.
Publicado: (1993) -
Stereocalpin B, a New Cyclic Depsipeptide from the Antarctic Lichen Ramalina terebrata
por: Lee, Seulah, et al.
Publicado: (2022)